Interdisciplinary Bio Central

Korean Society for Bioinformatics (한국생명정보학회)
권호 표지
DOI QR코드

DOI QR Code

Inferring Relative Activity between Pathway and Downstream Genes to Classify Melanoma Cancer Progression

  • Received : 2011.02.15
  • Accepted : 2011.02.18
  • Published : 2011.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Introduction: Many signal transduction pathways mediate cell's behavior by regulating expression level of involved genes. Abnormal behavior indicates loss of regulatory potential of pathways, and this can be attributed to loss of expression regulation of downstream genes. Therefore, function of pathways should be assessed by activity of a pathway itself and relative activity between a pathway and downstream genes, simultaneously. Results and Discussion: In this study, we suggested a new method to assess pathway's function by introducing concept of 'responsiveness'. The responsiveness was defined as a relative activity between a pathway itself and its downstream genes. The expression level of a downstream gene as a function of an upstream pathway activation characterizes disease status. In this aspect, by using the responsiveness we predicted potential progress in cancer development. We applied our method to predict primary and metastatic status of melanoma cancer. The result shows that the responsiveness-based approach achieves better performance than using gene or pathway information alone. The mean of ROC scores in the responsiveness-based approach was 0.90 for GSE7553 data set, increased more than 40% compared to a gene-based method. Moreover, identifying the abnormal regulatory patterns between pathway and its downstream genes provided more biologically interpretable information compared to gene or pathway based approaches.

Keywords

References

  1. Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., et al. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511. https://doi.org/10.1038/35000501
  2. Golub, T.R., Slonim, D.K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J.P., Coller, H., Loh, M.L., Downing, J.R., Caligiuri, M.A., et al. (1999). Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537. https://doi.org/10.1126/science.286.5439.531
  3. Tibshirani, R., Hastie, T., Narasimhan, B., and Chu, G. (2002). Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 99, 6567-6572. https://doi.org/10.1073/pnas.082099299
  4. Tusher, V.G., Tibshirani, R., and Chu, G. (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98, 5116-5121. https://doi.org/10.1073/pnas.091062498
  5. Chuang, H.Y., Lee, E., Liu, Y.T., Lee, D., and Ideker, T. (2007). Network-based classification of breast cancer metastasis. Mol Syst Biol 3, 140.
  6. Lee, E., Chuang, H.Y., Kim, J.W., Ideker, T., and Lee, D. (2008). Inferring pathway activity toward precise disease classification. PLoS Comput Biol 4, e1000217. https://doi.org/10.1371/journal.pcbi.1000217
  7. Taylor, I.W., Linding, R., Warde-Farley, D., Liu, Y., Pesquita, C., Faria, D., Bull, S., Pawson, T., Morris, Q., and Wrana, J.L. (2009). Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol 27, 199-204. https://doi.org/10.1038/nbt.1522
  8. Fung, M.M., Chu, Y.L., Fink, J.L., Wallace, A., and McGuire, K.L. (2005). IL-2- and STAT5-regulated cytokine gene expression in cells expressing the Tax protein of HTLV-1. Oncogene 24, 4624-4633. https://doi.org/10.1038/sj.onc.1208507
  9. Haider, A.S., Peters, S.B., Kaporis, H., Cardinale, I., Fei, J., Ott, J., Blumenberg, M., Bowcock, A.M., Krueger, J.G., and Carucci, J.A. (2006). Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J Invest Dermatol 126, 869-881. https://doi.org/10.1038/sj.jid.5700157
  10. Sosman, J.A., and Puzanov, I. (2006). Molecular targets in melanoma from angiogenesis to apoptosis. Clin Cancer Res 12, 2376s-2383s. https://doi.org/10.1158/1078-0432.CCR-05-2558
  11. Riker, A.I., Enkemann, S.A., Fodstad, O., Liu, S., Ren, S., Morris, C., Xi, Y., Howell, P., Metge, B., Samant, R.S., et al. (2008). The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 1, 13. https://doi.org/10.1186/1755-8794-1-13
  12. Xu, L., Shen, S.S., Hoshida, Y., Subramanian, A., Ross, K., Brunet, J.P., Wagner, S.N., Ramaswamy, S., Mesirov, J.P., and Hynes, R.O. (2008). Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol Cancer Res 6, 760-769. https://doi.org/10.1158/1541-7786.MCR-07-0344
  13. Prasad, T.S., Kandasamy, K., and Pandey, A. (2009). Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology. Methods Mol Biol 577, 67-79. https://doi.org/10.1007/978-1-60761-232-2_6
  14. Gribskov, M., and Robinson, N.L. (1996). Use of receiver operating characteristic (ROC) analysis to evaluate sequence matching. Comput Chem 20, 25-33. https://doi.org/10.1016/S0097-8485(96)80004-0